News About: Pharm. Industry
Generic giants to get easier access to Korean pharmaceutical market
The government plans to slash the price of about half the drugs on the market by an average of 14 percent starting next April.
The price cuts, designed to reduce national health insurance expenditures, left pharmac...
Boryung to boost sales of Kanarb in Central and South America
Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, said recently that it will strengthen a strategic alliance with Stendhal SA, a leading pharmaceutical firm in Mexico in an effort to expand ...
Restructuring plans in pharmaceutical firms hit snag
Influenced by the government’s large drug price cuts, many pharmaceutical companies are trying to survive through a massive reconstructing plan, but they are facing a strong resistance from sales persons.
A report ...
Zuellig, Hanwha Pharma agree to establish ties
Zuellig Pharma Korea has forged an alliance with Hanwha Pharmaceutical.
Under the deal, Zuellig will be in charge of distributing Hanwha over-the-counter (OTC) drugs and one health product using its extensive dome...
New Cinfa Korea president to start work
Laboratorios Cinfa, Spain's leading pharmaceutical company in sales by volume through retail pharmacies, and Spain's second leading pharmaceutical company, says that Lee Joo-chul, former executive of GlaxoSmithKline i...
Rheumatoid-arthritis drug Remicade price to be slashed
Janssen Korea said yesterday that its rheumatoid-arthritis medication Remicade 100 mg (infliximab) will be reduced by 3.9 percent to 557,332 won per bottle from Dec. 1 as the Ministry of Health and Welfare has decided...
Most firms sweating on product restructuring
A majority of Korean pharmaceutical companies are still struggling to finalize their product restructuring plans for the new year, according to pharmaceutical industry sources
The government’s large price cut plan ...
New factor Xa inhibitor shows promiseGreen Cross Corp. said Wednesday it has received approval from the U.S. Food and Drug Administration to conduct Phase 1 clinical trial of a novel anti-thrombotic which can be cl...
|
Health minister, FKCU to meet over drug pricing reform
Attention has been drawn over the proposed meeting between Health and Welfare Minister Rim Che-min and representatives from the Federation of Korean Chemical Workers Union (FKCU) on December 7.
So far, the FKCU cla...
Drug makers stalling on 2012 business plan
Weighed down by the imminent large price cuts and Assembly’s ratification of the new Korea-U.S. free trade agreement, domestic pharmaceutical firms are delaying the formulation of their business plans for next year.
...
